Advagene Biopharma Co., Ltd. (TPEX:6709)
19.90
-0.20 (-1.00%)
Nov 20, 2026, 1:58 PM CST
| Market Cap | 1.18B -28.9% |
| Revenue (ttm) | n/a |
| Net Income | -91.05M |
| EPS | -1.52 |
| Shares Out | 59.38M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 98,252 |
| Open | 19.50 |
| Previous Close | 20.10 |
| Day's Range | 19.20 - 20.10 |
| 52-Week Range | 19.20 - 36.15 |
| Beta | 0.66 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Mar 5, 2027 |